An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
Clinical trial NCT04146324 · COMPLETED
Trial details
- NCT number
- NCT04146324
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-12
- Primary completion
- 2024-05-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.